Ligand validation:6I6K

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 6I6K designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6I6K_SAH_A_402	99%	37%	0.055	0.986	1.2	1.25	1	1	0	0	100%	1
6I6K_SAH_B_402	98%	36%	0.062	0.985	1.28	1.23	2	2	0	0	100%	1
6I6M_SAH_B_402	99%	40%	0.056	0.99	1.04	1.31	2	1	0	0	100%	1
6I6L_SAH_B_402	99%	34%	0.052	0.983	0.97	1.61	1	3	1	0	100%	1
6I6N_SAH_A_402	98%	53%	0.062	0.984	0.63	1.19	-	1	0	0	100%	1
6I5Z_SAH_A_401	56%	11%	0.191	0.964	1.48	2.62	3	8	2	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
2BB3_SAH_B_203	100%	9%	0.027	0.993	2.32	2.18	9	6	4	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
6U8W_SAH_A_901	100%	22%	0.028	0.995	1.23	1.96	3	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.